Desquamative Dermatitis Caused by Erlotinib: An Underreported Cutaneous Adverse Event.
Publication/Presentation Date
1-1-2016
Volume
14
Issue
5
First Page
383
Last Page
384
ISSN
1540-9740
Published In/Presented At
Vega, M. L., Yin, N. C., & Keller, M. (2016). Desquamative Dermatitis Caused by Erlotinib: An Underreported Cutaneous Adverse Event. Skinmed, 14(5), 383–384.
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
27871355
Department(s)
Administration and Leadership
Document Type
Article
COinS